ChemoMetec A/S updated earnings guidance for the fiscal year 2022/2023. For the year, the company expected revenue of DKK 430 million - DKK 460 million, against the previous guidance of DKK 485 million-DKK 505 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
359.3 DKK | -1.99% | +0.95% | -6.49% |
10:19am | Denmark's ChemoMetec Appoints New CFO | MT |
May. 24 | ChemoMetec A/S Announces CFO Changes | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.49% | 928M | |
+75.35% | 12.55B | |
-23.01% | 7.51B | |
+8.35% | 6.74B | |
+14.40% | 5.47B | |
-13.95% | 4.89B | |
+32.74% | 4.74B | |
-22.92% | 3.7B | |
-23.06% | 2.9B | |
+55.06% | 2.49B |
- Stock Market
- Equities
- CHEMM Stock
- News ChemoMetec A/S
- ChemoMetec A/S Updates Earnings Guidance for the Fiscal Year 2022/2023